retatrutide fda approval status 2025 approves this year? Predictions & Odds 2026 There's lots going on this

Across TRIUMPH-1 and TRANSCEND-T2D-1, retatrutide delivered substantial weight loss, meaningful A1C reduction, and improvements in knee osteoarthritis pain and moderate-to-severe obstructive sleep apnea, a breadth and magnitude of outcomes thats striking to see with a single therapy, says Kenneth Custer, PhD, executive vice president and president, Lilly Cardiometabolic Health, in a release

You have to do weight management if you want [GLP-1 drugs] for weight loss

This is a metabolic pathway that neither GLP-1 nor GIP activation can access with the same potency

Once prescribed mainly for diabetes management, they are now widely recognized for their ability to drive significant and sustained fat reduction

2025 Nov;33(11):2046-2054

"People may have lower cravings for food, gambling, alcohol, and potentially sex